Although the US presidential election is over, WikiLeaks is continuing to publish the emails of Hillary Clinton’s campaign chair John Podesta, who remains a major player in Washington. This is the 36th batch of emails, released in a constant drip over the past month.
The whistleblowing website has published close to 56,000 emails from Podesta’s private account since October 7, sometimes more than once a day, revealing the internal communications of Clinton’s campaign staff.
Media and big banks
In an email dated February 10, 2014, Washington Post journalist Dan Balz messaged Thomas Nides, Clinton’s former deputy secretary of state, to give him a heads-up regarding a rumored expose on the Clintons being written by the New York Times.
“Confidentially: Rumors around that the NYT is digging into Clinton/Bill Clinton and ready to pop something. Do you know what this is about?” wrote Balz, who has been a political correspondent with the Post since 1978. Nides, who was back at the helm of investment bank Morgan Stanley at the time, forwarded the email to Cheryl Mills, one of Hillary Clinton’s top aides.
Mills in turn forwarded the email to Podesta, who held the position of Counselor to President Obama at the time.
A previously released email showed Nides – who is married to CNN vice president Virginia Moseley – sharing information on a CNN poll with Podesta before it became public.
In another message, he advised Podesta on the matter of Clinton’s email scandal to “get a State Department career lawyer to go through all the emails and pull the official ones.”
On March 14 this year, Center for American Progress director Neera Tanden emailed Podesta a tweet by liberal blogger Ezra Klein, calling the upcoming Clinton fundraiser with Theranos CEO Elizabeth Holmes a “bad idea.”
“Great minds think alike,” Podesta replied.
The March 21 fundraiser still happened, but was relocated from its original venue at Theranos headquarters in Silicon Valley to Holmes’ residence.
Although Holmes attracted hundreds of millions in venture capital funding by touting a revolutionary blood-testing technology, Theranos was found to have outsourced their tests or used existing technology instead, and is currently under federal investigation for misleading investors.
Source: Word News